UB, partner awarded $3 million NIH grant to study immune cell therapy for tumors

The work could improve a promising type of immunotherapy
treatment — chimeric antigen receptor (CAR) T-cell
therapy.

Related articles

UB study shows that key protein can slow aging

Published findings, led by oral biology professor Keith Kirkwood, reveal...

The Upside Down World of the Buffoonish Ed Martin

Hoisted on His Own Petard In the roughshod world of the Trump Justice Department, politicized prosecutions are fine, but Ed...